In a collaboration that promises to accelerate cutting-edge research and foster tomorrow’s medical discoveries, Stony Brook Medicine and Mount Sinai Health System have entered into an affiliation agreement aimed at heightening research collaboration and enhancing academic programs and clinical care initiatives.
Stony Brook University President Samuel L. Stanley Jr., MD, (center) shakes hands with Kenneth Kaushansky, MD, Senior VP, Health Sciences and Dean, Stony Brook University School of Medicine (left), and Dennis S. Charney, MD, the Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President, Academic Affairs, Mount Sinai Health System (right) after signing the affiliation agreement.
“This is a momentous day for academic medicine, health care, our respective students, faculty and staff, and for all those who are cared for by our teams of highly trained, dedicated clinicians,” said Stony Brook University President Samuel L. Stanley Jr., MD. “Each institution has so much to offer, so this is an opportunity that will prove to be beneficial for all — now and in the future — as we explore and grow this incredible collaboration.”
Combining expertise from two premier medical schools, the partnership offers boundless opportunities to promote discovery, enrich academic medicine and enhance clinical care through large-scale research and clinical collaborations that will transform healthcare from Manhattan to Montauk and beyond.
Stony Brook University and the Icahn School of Medicine
at Mount Sinai will collaborate to develop a wide range of research programs in fields including biomedical engineering and computer science; drug discovery and medicinal chemistry sciences; neuroscience, neurology and psychiatry; basic biology and novel therapeutics; and, public health and health systems.
The alliance will capitalize on Stony Brook’s expertise in mathematics, high-performance computing, imaging, and the physical and chemical sciences, tapping resources from the College of Engineering and Applied Sciences
and College of Arts and Sciences
. Combined with Mount Sinai’s strengths in biomedical and clinical research, and health policy and outcomes, the partnership promises to expand the pursuit of the big ideas and imaginative solutions that will shape the future.
Leaders from Stony Brook University and the Mount Sinai Health System, along with elected officials, assemble at the affiliation agreement signing event at Stony Brook Medicine. From left: Assemblyman Steven Englebright; Scott Friedman, MD, Dean of Therapeutic Discovery at Icahn School of Medicine at Mount Sinai; Dennis S. Charney, MD, the Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai and President of Academic Affairs, Mount Sinai Health System; Samuel L. Stanley Jr., MD, President of Stony Brook University; Kenneth Kaushansky, MD, Senior VP, Health Sciences and Dean, Stony Brook University School of Medicine; Senator Kenneth LaValle; Senator Kemp Hannon; and Lina Obeid, MD, Dean for Research and Vice Dean for Scientific Affairs, Stony Brook University School of Medicine.
“The opportunities for amazing science to spring from our collaborative efforts are truly boundless,” said Kenneth Kaushansky, MD, Senior Vice President for Health Sciences, and Dean of the Stony Brook University School of Medicine. “When you bring the intellectual and biomedical horsepower of the Icahn School of Medicine faculty together with the outstanding neuroscientists, cancer biologists, imaging innovators, cardiovascular experts, and leading biomedical informaticists of the Stony Brook School of Medicine, as well as the world-class departments of computer sciences, biomedical engineering, chemistry, and applied mathematics at Stony Brook University, the possibilities are staggering.”
Through the partnership, the schools will develop joint graduate and medical educational programs in all areas, leveraging the strength of existing master’s and doctoral programs at each institution. Students will have the opportunity to take classes on both campuses, allowing them to learn new techniques and expand their learning capacity. Mount Sinai and Stony Brook will also build summer programs for undergraduate, graduate, and postgraduate students.
In addition, Mount Sinai and Stony Brook will invest a combined $500,000 to launch competitive and unique pilot programs, with the intent to receive collaborative external funding. Projects will be determined and overseen by a committee composed of three representatives from each institution.
“Major breakthroughs in improving diagnostics and therapeutics in health care come from research, usually starting at the very basic level and moving into translational and clinical research and eventually to the bedside,” said Lina Obeid, MD, Dean for Research and Vice Dean for Scientific Affairs at Stony Brook University School of Medicine. “Stony Brook Medicine and the Icahn School of Medicine at Mount Sinai are two powerhouses of research that when partnered will definitely yield greater discoveries than just the sum of their parts. The joint pilots in research have immense promise to advance health at the most exciting time in the biomedical sciences, including advanced computational, bioinformatic, and engineering approaches.”